Related Experiment Video
Updated: Apr 6, 2026

Using Caco-2 Cells to Study Lipid Transport by the Intestine
Published on: August 20, 2015
Insight into the mechanism of lipids binding and uptake by CD36 receptor
Zineb Tarhda1, Azeddine Ibrahimi1
1Biotechnology lab (MedBiotech), Faculté de Médecine et de Pharmacie de Rabat, Université Mohammed V, Rabat, Morocco.
Insights
Researchers modeled the CD36 receptor structure to understand how fatty acids bind, revealing potential therapeutic targets for cardiovascular and metabolic diseases.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- CD36 is a scavenger receptor implicated in cardiovascular and metabolic diseases.
- Its precise mechanism of action is poorly understood due to the lack of a determined 3D structure.
- Understanding CD36 interactions is vital for developing targeted therapies.
Purpose of the Study:
- To predict the 3D structure of the CD36 extracellular domain.
- To investigate the binding mechanism of long-chain fatty acids (LCFAs) to CD36.
- To identify potential therapeutic strategies targeting CD36.
Main Methods:
- Molecular docking simulations were employed to model CD36-ligand interactions.
- Physicochemical evaluations validated the predicted CD36 structure.
- Analysis focused on key residues and potential binding sites for LFCAs.
Main Results:
- A reliable 3D structure model of the CD36 extracellular domain was successfully predicted.
- Docking outcomes elucidated the step-by-step mechanism of fatty acid binding and cellular uptake.
- Key regions involved in LCFAs binding were identified.
Conclusions:
- The study provides a structural basis for understanding CD36-fatty acid interactions.
- The findings highlight CD36 as a promising therapeutic target for metabolic and cardiovascular conditions.
- The proposed mechanism offers insights for designing CD36 antagonists.
Abstract:
The membrane protein CD36 is a member of the class B scavenger receptor family. It plays a crucial role in some cardiovascular pathologies and metabolic diseases. Studying the mechanism of action of CD36 receptor is limited due to the absence of its tridimensional crystallized structure. The molecular docking method has allowed us to perform various simulation of the CD36 receptor interaction with their ligands involved in the development of some diseases. In this work, we predicted a tridimensional structure model of CD36 extracellular domain. In addition, we have achieved several tests of rigid and flexible docking by acting on residues proposed in previous experimental researches as essential in fixing of LFCAs. Furthermore, we have acted on regions that appear a key binding site of LFCAs. The physicoc hemical evaluation indicated the reliability of the proposed CD36 structure used for different molecular docking tests. Based on the docking outcome, we were able to propose the different steps of the mechanism allowing the interaction of fatty acids on CD36 receptor and their penetration into the cell cytoplasm. The obtained results and taking in consideration CD36 receptor as a therapeutic target will help us to suggest the mechanism by which an antagonist may inhibit this receptor by acting on its extracellular domain.
Related Concept Videos
Receptor-mediated Endocytosis
Receptor-mediated Endocytosis
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Receptor-Mediated Endocytosis
Lipid Absorption
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains...

